What is the mode of administration for teriflunomide (Gezyme)?

Teriflunomide, marketed under the brand name Gezyme, is administered orally in the form of a capsule. This route of administration allows for convenient dosing, as patients can take the medication at home without the need for injections or infusions. Oral administration also facilitates better adherence to treatment regimens, as patients prefer taking medication in a non-invasive manner.

In contrast, intravenous and intramuscular injections require clinical or healthcare provider visits, which can lead to less consistent use due to logistical challenges or discomfort associated with injections. Subcutaneous administration, while also less invasive than intravenous or intramuscular options, still requires patients to manage an injection process, which can impact adherence and patient comfort levels.

Thus, the oral capsule administration for teriflunomide stands out as the most patient-friendly option, aligning with the goals of treatment in multiple sclerosis to enhance patient compliance and quality of life.